SAFETY AND EFFICACY OF ORAL V/S VAGINALLY ADMINISTERED MISOPROSTOL FOR INDUCTION OF LABOUR IN TERM PREGNANCIES- A RANDOMISED CONTROLLED TRIA

MOSC MEDICAL COLLEGEKOLENCHERY0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•Nulliparous and Multiparous women at term(37-42 completed weeks of gestation with first trimester ultrasound confirmed dates),with a singleton fetus of Cephalic presentation with :
•Clinically adequate pelvis
•Reassuring fetal heart tracing,
•,Modified bishopâ??s score of less than 6
•[1]Gestational diabetes mellitus,
•[2] gestational hypertension,
•[3]past date,
•[4]oligohydramnios,
•[5]Premature rupture of membranes[ <6hours]
•Are eligible for this trial

•All patients with [1]severe systemic illnesses like uncontrolled diabetes mellitus, severe pre-eclampsia, cardiac, renal or hepatic disease,
•[3]intrauterine deaths
•[4]hypersensitivity to misoprostol or any prostaglandin analogue
•[5] Patients with any contraindication to induction and vaginal delivery, e.g. cephalopelvic disproportion, malpresentation, fetal compromise, non reassuring fetal heart rate pattern, previous scar and ante partum haemorrhage.
•[6] Patients who are not willing to participate in this study

发起方

MOSC MEDICAL COLLEGEKOLENCHERY